Clinical Trials Logo

Clinical Trial Summary

The aim of this clinical trial is to assess the efficacy of tesamorelin as a therapy for peripheral nerve injuries. The investigators hypothesize that treatment with tesamorelin will allow for faster and greater recovery of motor and sensory function following surgical repair of injured peripheral nerves. Patients with upper extremity nerve injuries will be randomly assigned to receive either the drug or a placebo (inactive drug). A number of tests for nerve regeneration, muscle function and sensation will be performed every month for a total of 12 months. Outcomes in the patients treated with tesamorelin will be compared to outcomes in patients who received the placebo to determine the effectiveness of tesamorelin as a therapy for nerve injuries.


Clinical Trial Description

This is a multi-institutional, randomized, double-blinded, placebo-controlled clinical trial assessing the efficacy of tesamorelin as a therapy to improve functional recovery following peripheral nerve injury. Tesamorelin is a drug that stimulates increased production of growth hormone, and growth hormone has been shown to improve nerve regeneration and functional recovery in animal studies. A total of 36 participants with repaired ulnar nerve lacerations will be enrolled, of which 18 will be randomly assigned to receive the study drug and 18 will receive the placebo. To avoid bias, the study participants and investigators will be blinded to the treatment group assignments. Following enrollment, each participant will have 12 monthly follow-up visits during which participants will undergo testing to assess recovery. Outcome assessments will include clinical exams, MRI, electrodiagnostic studies and questionnaires. The total duration of the study is expected to be 4 years. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03150511
Study type Interventional
Source Johns Hopkins University
Contact Sami Tuffaha, MD
Phone 410-614-4333
Email stuffah1@jhmi.edu
Status Recruiting
Phase Phase 2
Start date June 1, 2018
Completion date December 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04572906 - Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries Phase 2
Active, not recruiting NCT03999424 - Autologous Human Schwann Cells in Peripheral Nerve Repair Phase 1
Not yet recruiting NCT05848778 - Non-invasive Therapy to Drive Nerve Regeneration N/A
Completed NCT02070367 - Somatosensory Assessment and Rehabilitation of Allodynia (SARA) N/A
Recruiting NCT03205124 - The Effect of Pre-operative Electrical Stimulation on Peripheral Nerve Regeneration. Phase 2/Phase 3
Recruiting NCT01526681 - Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
Recruiting NCT03422107 - Somatosensory Evoked Potential (SSEP) Monitoring for Detection of Intraoperative Positional Neuropraxia N/A
Active, not recruiting NCT05339594 - REINVENT Registry (Registry of the Nerve Gap Repair From Integra)
Completed NCT02437695 - Robot Assisted Radical Prostatecomy and Positional Injury N/A
Completed NCT02786888 - Prospective Comparison of Adductor Canal Block Performed With a Multiport Versus Single Bevel Needle N/A
Completed NCT01954199 - The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain N/A
Withdrawn NCT02095899 - Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome Phase 2
Recruiting NCT02403661 - Electrical Stimulation to Enhance Peripheral Nerve Regeneration N/A
Completed NCT03191032 - Early Sensory Re-education of the Hand With a Sensor Glove Model N/A
Recruiting NCT06209801 - Mirror Therapy Integrated With Electrical Stimulation for Cortical Modulations N/A
Recruiting NCT03913689 - StimRouter Registry Clinical Protocol
Terminated NCT02459015 - Performance Study of an Artificial Nerve Guide (Reaxon® Nerve Guide) to Treat Digital Nerve Lesions N/A
Recruiting NCT03780855 - Preliminary Evaluation of the Clinical Safety and Effectiveness of the Bionic Nerve Scaffold N/A
Recruiting NCT05884125 - Promoting Healing of Injured Nerves With Electrical Stimulation Therapy N/A
Recruiting NCT04789044 - Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion) Phase 2